Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

15 avr. 2019 08h00 HE | Source: iCAD, Inc.

iCAD Wins Three-System Public Bid with Leading Cancer Organization in Spain, Expanding European Access to Innovative Cancer Treatments with the Xoft System

Two additional Spanish centers announce adoption of the Xoft System, totaling seven installations across four major regions in Spain Internationally-recognized institutions strengthen portfolio of...
04 avr. 2019 10h53 HE | Source: iCAD, Inc.

iCAD to Highlight ProFound AI™ Solution for Digital Breast Tomosynthesis at 2019 Society of Breast Imaging Annual Symposium

NASHUA, N.H., April 04, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
28 mars 2019 08h22 HE | Source: iCAD, Inc.

iCAD Appoints Stacey Stevens as President

Appointment establishes executive infrastructure to enhance strategic and operational momentum and capitalize on significant growth opportunities Announcement follows pivotal FDA clearance and...
26 mars 2019 08h00 HE | Source: iCAD, Inc.

iCAD to Present Corporate Overview at the Jefferies 2019 Radiation Oncology & Energy-Based Therapeutics Summit

NASHUA, N.H., March 26, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...
18 mars 2019 16h01 HE | Source: iCAD, Inc.

iCAD Reports Fourth Quarter and Full-Year 2018 Financial Results

Company achieved key milestone in fourth quarter with FDA clearance and subsequent U.S. commercial launch of ProFound AI™ for digital breast tomosynthesis Conference call today at 4:30 p.m. ET ...
14 mars 2019 08h00 HE | Source: iCAD, Inc.

iCAD to Present Corporate Overview at the 31st Annual ROTH Conference

NASHUA, N.H., March 14, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...
13 mars 2019 16h30 HE | Source: iCAD, Inc.

iCAD to Report Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results on Monday, March 18

NASHUA, N.H., March 13, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
27 févr. 2019 16h30 HE | Source: iCAD, Inc.

iCAD to Partner with Leading Breast Cancer Researchers from Karolinska Institutet to Develop Artificial Intelligence-Based Breast Cancer Risk Prediction Solution

VIENNA, Austria, Feb. 27, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced their...
21 févr. 2019 11h12 HE | Source: iCAD, Inc.

iCAD to Showcase ProFound AI™ Solution for Digital Breast Tomosynthesis at ECR 2019

NASHUA, N.H., Feb. 21, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
07 janv. 2019 08h00 HE | Source: iCAD, Inc.

Long-Term Study of 1,000 Tumors Demonstrates Effectiveness of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment

Prospective trial shows that intraoperative radiation therapy (IORT) is a clinically effective, faster and easier alternative to whole breast radiation therapy following breast-conserving surgery for...

Page précédente